[Periprosthetic Infection of the Knee Megaprosthesis following a Resection of Malignant Tumours around the Knee].

PURPOSE OF THE STUDY The study presents the monocentric retrospective study of a group of patients with malignant tumours around the knee, treated by a wide resection and a reconstruction with megaprosthesis due to infectious complications. Provided is a detailed analysis of each operative treatment due to the manifestation and process of periprostethic infection of the knee megaprosthesis and the use of external fixator during a two-stage revision. MATERIAL AND METHODS Between 01/1993 and 12/2013, a total of 67 cemented megaprostheses were assessed, with a detailed analysis of 12 patients with periprosthetic infection. The Kaplan-Meier method and MSTS for lower extremity clinical assessment were used and a range of motion was evaluated. RESULTS The endoprosthesis failed due to all kinds of complications (mechanical, biological, infection) in 27 (40.3%) patients. The estimated one-year survival rate from the surgery was 94%, the five-year survival rate was 72%, and the ten-year survival rate was 46%. Based on the statistical analysis of the implant survival due to infection, the one-year survival rate was 94%, the five-year survival rate was 75%, and the ten-year survival rate was 57%. Three patients were treated with radical surgical debridement. Five patients were treated with a two-stage revision with a cement spacer and external fixator, and three patients underwent nail fixation. Clinical values before and two years after the revision surgery for periprosthetic infection using MSTS were assessed. The mean of the difference of clinical values was 1.91 and the p value of paired t-test was 0.24, therefore there was no prove of the clinical result difference using MSTS before and after the revision surgery. DISCUSSION The acute radical debridement and lavage is preferred, if the surgery can be done up to three weeks after the first clinical signs of infection under the condition of good retention of the implant. In case of extensive infectious damage, when abscess, fistula and loosening of the implant are present and when the patient has a good oncological prognosis, we prefer a twostage revision with a cement spacer stabilized by an external fixator. In patients with mitigated infection or uncertain oncological prognosis we prefer a two-stage revision with the combination of a cement spacer and intramedullary nail fixation. CONCLUSIONS The study presents the results of operative treatment of periprosthetic infection of megaprosthesis and the modification of the two-stage replantation of infected MP with the use of external fixation for stabilisation of a non-articulated cement spacer allowing the patient to remain active during the time before the second stage. Key words: periprosthetic infection, megaprosthesis, bone tumour, external fixator, two-stage revision.

[1]  E. Ahlmann,et al.  Peri-Prosthetic Infection in the Orthopedic Tumor Patient , 2014 .

[2]  Calin S. Moucha,et al.  Antibacterial Surface Treatment for Orthopaedic Implants , 2014, International journal of molecular sciences.

[3]  F. Farrokhyar,et al.  High Infection Rate Outcomes in Long-bone Tumor Surgery with Endoprosthetic Reconstruction in Adults: A Systematic Review , 2013, Clinical orthopaedics and related research.

[4]  R. Lackman,et al.  Perioperative Infection Rate in Patients with Osteosarcomas Treated with Resection and Prosthetic Reconstruction , 2011, Clinical orthopaedics and related research.

[5]  F. Hornicek,et al.  Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. , 2011, The Journal of bone and joint surgery. American volume.

[6]  M. Balke,et al.  Reduction of periprosthetic infection with silver‐coated megaprostheses in patients with bone sarcoma , 2010, Journal of surgical oncology.

[7]  A. Port,et al.  Direct exchange endoprosthetic reconstruction with tumour prosthesis for periprosthetic knee infection associated with segmental bone defects , 2010, Strategies in trauma and limb reconstruction.

[8]  I. Sim,et al.  Salvaging the limb salvage: management of complications following endoprosthetic reconstruction for tumours around the knee. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  R. Tillman,et al.  Post Operative Infection and Increased Survival in Osteosarcoma Patients: Are They Associated? , 2007, Annals of surgical oncology.

[10]  M. Isler,et al.  Experience with Cemented Large Segment Endoprostheses for Tumors , 2007, Clinical orthopaedics and related research.

[11]  E. Ahlmann,et al.  Survivorship and clinical outcome of modular endoprosthetic reconstruction for neoplastic disease of the lower limb. , 2006, The Journal of bone and joint surgery. British volume.

[12]  P. Cordeiro,et al.  Limb Salvage of Infected Knee Reconstructions for Cancer With Staged Revision and Free Tissue Transfer , 2006, Annals of plastic surgery.

[13]  W. Winkelmann,et al.  Characteristics and outcome of infections associated with tumor endoprostheses , 2006, Archives of Orthopaedic and Trauma Surgery.

[14]  A. Leithner,et al.  [Revision of tumour endoprostheses around the knee joint. Review and own results]. , 2006, Der Orthopade.

[15]  R. Windhager,et al.  Wechsel von Tumorendoprothesen des Kniegelenks , 2006, Der Orthopäde.

[16]  W. Zimmerli,et al.  Prosthetic joint infections: update in diagnosis and treatment. , 2005, Swiss medical weekly.

[17]  J. Lonner,et al.  Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. , 2003, The Journal of arthroplasty.

[18]  R. Grimer,et al.  Risk of amputation following limb salvage surgery with endoprosthetic replacement, in a consecutive series of 1261 patients , 2003, International Orthopaedics.

[19]  V. Goldberg,et al.  Diagnosis and management of infection after total knee arthroplasty. , 2003, The Journal of bone and joint surgery. American volume.

[20]  R. Grimer,et al.  Two-Stage Revision for Infected Endoprostheses Used in Tumor Surgery , 2002, Clinical orthopaedics and related research.

[21]  R. Grimer,et al.  Prosthetic replacement of the distal femur for primary bone tumours. , 1991, The Journal of bone and joint surgery. British volume.

[22]  R. Van Scoy,et al.  Deep wound sepsis following total hip arthroplasty. , 1977, The Journal of bone and joint surgery. American volume.

[23]  A. Hanssen,et al.  Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  W. Winkelmann,et al.  Lack of toxicological side-effects in silver-coated megaprostheses in humans. , 2007, Biomaterials.

[25]  Frcs L. M. Jeys MSc,et al.  Post Operative Infection and Increased Survival in Osteosarcoma Patients: Are They Associated? , 2007, Annals of Surgical Oncology.

[26]  M. Cross,et al.  Arthroscopic debridement in the treatment of the infected total knee replacement. , 2004, The Journal of bone and joint surgery. British volume.

[27]  M. B. Coventry Treatment of infections occurring in total hip surgery. , 1975, The Orthopedic clinics of North America.